Feltl & Co Downgrades Insulet Corporation (PODD) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Insulet Reports First Quarter 2015 Financial Results
April 30, 2015 4:01 PM EDTBILLERICA, MA -- (Marketwired) -- 04/30/15 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced financial results for the three months ended March 31, 2015.
First Quarter Highlights and Recent Developments:
First quarter financial results: U.S. OmniPod revenue in-line with Company's expectations. Drug Delivery and International shipments planned for the first quarter now expected to be realized during remainder of 2015. Strengthened senior leadership team with appointment of highly-experienced Chief Financial Officer. Previously announced: First... More